Coronavirus disease 2019 (COVID-19) and prosthetic heart valve: An additional coagulative challenge
- PMID: 33014223
- PMCID: PMC7517399
- DOI: 10.5847/wjem.j.1920-8642.2020.04.009
Coronavirus disease 2019 (COVID-19) and prosthetic heart valve: An additional coagulative challenge
Conflict of interest statement
Conflicts of interest: There is no conflict of interest in this study.
References
-
- World Health Organization (WHO) Coronavirus disease (COVID-2019) situation reports. [Accessed on April 2 2020]. Available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio... .
-
- Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH. Antithrombotic and thrombolytic therapy for valvular disease:Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e576S–e600S. - PMC - PubMed
-
- Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116–20. - PubMed
Publication types
LinkOut - more resources
Full Text Sources